Statement on Celgene’s Revlimid Price Hike

CSRxP spokesman Will Holley released the following statement in response to today’s report that Celgene will once again raise the price of Revlimid: “Today’s announcement that […]

Read more

CSRxP Applauds Secretary Azar’s Focus on List Prices

CSRxP spokesman Will Holley released the following statement in response to Secretary Azar’s testimony in front of the Senate Finance Committee today: “The Administration’s focus on out-of-control […]

Read more

CSRxP Testimony for the Record: Senate Finance Committee Hearing on Rx Prices

The Campaign for Sustainable Rx Pricing today released testimony for the record submitted to the Senate Finance Committee in advance of tomorrow’s hearing, “Prescription Drug Affordability […]

Read more

CSRxP Applauds Senate Judiciary Committee for Vote on CREATES Act

“We applaud the members of the Senate Judiciary Committee for voting the CREATES Act out of committee and advancing this bipartisan legislation one step closer to […]

Read more